Drug intelligence / Profile preview

Solidago decurrens

Development stage: Preclinical
Modality: Small Molecules

Overview

Solidago decurrens (also known as Asian goldenrod) is a species of flowering plant in the family Asteraceae, native to East Asia. It is a perennial herb traditionally recognized for its anti-inflammatory, diuretic, and antimicrobial properties. The plant contains bioactive compounds such as flavonoids (e.g., quercetin and kaempferol) and saponins. It is being investigated for its potential therapeutic applications, including the treatment of acute lung injury and anti-adipogenesis.

Brand names: Yizhihuanghua GranulesYizhihuanghua Capsules
Other names: Solidago decurrens Lour.SdLAsian goldenrodDecurrent GoldenrodRunning Goldenrod

Targets

IL1B (Interleukin-1 beta)IL-6 (Interleukin 6)NF-κBNOS2 (Nitric Oxide Synthase 2)NLRP3 (Nod-like receptor family pyrin domain-containing protein 3)

Beyond the preview

Go deeper on Solidago decurrens.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Solidago decurrens.

Explore the full profile